-
1دورية أكاديمية
المؤلفون: Robert, Caroline, Hwu, Wen-Jen, Hamid, Omid, Ribas, Antoni, Weber, Jeffrey S, Daud, Adil I, Hodi, F Stephen, Wolchok, Jedd D, Mitchell, Tara C, Hersey, Peter, Dronca, Roxana, Joseph, Richard W, Boutros, Celine, Min, Le, Long, Georgina V, Schachter, Jacob, Puzanov, Igor, Dummer, Reinhard, Lin, Jianxin, Ibrahim, Nageatte, Diede, Scott J, Carlino, Matteo S, Joshua, Anthony M
المصدر: Robert, Caroline; Hwu, Wen-Jen; Hamid, Omid; Ribas, Antoni; Weber, Jeffrey S; Daud, Adil I; Hodi, F Stephen; Wolchok, Jedd D; Mitchell, Tara C; Hersey, Peter; Dronca, Roxana; Joseph, Richard W; Boutros, Celine; Min, Le; Long, Georgina V; Schachter, Jacob; Puzanov, Igor; Dummer, Reinhard; Lin, Jianxin; Ibrahim, Nageatte; Diede, Scott J; Carlino, Matteo S; Joshua, Anthony M (2021). Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma. European Journal of Cancer, 144:182-191.
مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health, Cancer Research, Oncology
وصف الملف: application/pdf
العلاقة: https://www.zora.uzh.ch/id/eprint/194653/1/868_Robert_C._et_al._Long-term_safety_of_pembrolizumab_monotherapy_and_relationship_with_clinical_outcome_EJC_2020.pdfTest; info:pmid/33360855; urn:issn:0959-8049
الإتاحة: https://doi.org/10.5167/uzh-19465310.1016/j.ejca.2020.11.010Test
https://www.zora.uzh.ch/id/eprint/194653Test/
https://www.zora.uzh.ch/id/eprint/194653/1/868_Robert_C._et_al._Long-term_safety_of_pembrolizumab_monotherapy_and_relationship_with_clinical_outcome_EJC_2020.pdfTest -
2دورية أكاديمية
المؤلفون: Robert, Caroline, Hwu, Wen-Jen, Hamid, Omid, Ribas, Antoni, Weber, Jeffrey S., Daud, Adil I., Hodi, F. Stephen, Wolchok, Jedd D., Mitchell, Tara C., Hersey, Peter, Dronca, Roxana, Joseph, Richard W., Boutros, Celine, Min, Le, Long, Georgina V., Schachter, Jacob, Puzanov, Igor, Dummer, Reinhard, Lin, Jianxin, Ibrahim, Nageatte, Diede, Scott J., Carlino, Matteo S., Joshua, Anthony M.
المساهمون: Intégrité du génome, ARN et cancer, Institut Curie Paris -Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR), Prédicteurs moléculaires et nouvelles cibles en oncologie (PMNCO), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, The University of Texas M.D. Anderson Cancer Center Houston, The Angeles Clinic and Research Institute, University of California (UC), NYU Langone Health New York, University of California San Francisco (UC San Francisco), Dana-Farber Cancer Institute Boston, Memorial Sloane Kettering Cancer Center New York, Abramson Cancer Center, University of Pennsylvania-Perelman School of Medicine, University of Pennsylvania, The University of Sydney, Mayo Clinic Rochester, Mayo Clinic Jacksonville, Harvard Medical School Boston (HMS), Chaim Sheba Medical Center, Roswell Park Comprehensive Cancer Center, Universität Zürich Zürich = University of Zurich (UZH), Merck Sharp and Dohme (Merck & Co. Inc), Westmead Hospital Sydney, Blacktown Hospital, University Health Network Toronto, ON, Canada, Cancer Division Sydney, Australia (The Kinghorn Cancer Centre), Garvan Institute of medical research, St. Vincent’s Clinical School Sydney, Australia, UNSW Faculty of Medicine Sydney, University of New South Wales Sydney (UNSW)-University of New South Wales Sydney (UNSW)
المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-03492707Test ; European Journal of Cancer, 2021, 144, pp.182 - 191. ⟨10.1016/j.ejca.2020.11.010⟩.
مصطلحات موضوعية: [SDV]Life Sciences [q-bio]
العلاقة: hal-03492707; https://hal.science/hal-03492707Test; PII: S0959-8049(20)31333-2; PUBMEDCENTRAL: PMC8388128
-
3دورية أكاديمية
المؤلفون: Weppler, Alison M., Da Meda, Laetitia, Pires da Silva, Ines, Xu, Wen, Grignani, Giovanni, Menzies, Alexander M., Carlino, Matteo S., Long, Georgina V., Lo, Serigne N., Nordman, Ina, Steer, Christopher B., Lyle, Megan, Trojaniello, Claudia, Ascierto, Paolo A., Lebbe, Celeste, Sandhu, Shahneen
وصف الملف: application/pdf
العلاقة: https://doi.org/10.1016/j.ejca.2023.01.016Test; https://researchonline.jcu.edu.au/78339Test/; https://researchonline.jcu.edu.au/78339/1/78339.pdfTest; Weppler, Alison M., Da Meda, Laetitia, Pires da Silva, Ines, Xu, Wen, Grignani, Giovanni, Menzies, Alexander M., Carlino, Matteo S., Long, Georgina V., Lo, Serigne N., Nordman, Ina, Steer, Christopher B., Lyle, Megan, Trojaniello, Claudia, Ascierto, Paolo A., Lebbe, Celeste, and Sandhu, Shahneen (2023) Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation. European Journal of Cancer, 183. pp. 109-118.
-
4دورية أكاديمية
المؤلفون: Scolyer, Richard A., Atkinson, Victoria, Ch'ng, Sydney, Colebatch, Andrew J., Daneshvar, Dariush, Pires da Silva, Ines, Dawson, Tamara, Ferguson, Peter M., Foster-Smith, Erwin, Fox, Stephen B., Gill, Anthony J., Gupta, Ruta, Gyorki, David E., Henderson, MA, Hong, AM, Howle, JR, Jackett, LA, James, C, Lee, CS, Lochhead, A, Loh, D, McArthur, GA, McLean, CA, Lambie, Duncan, Menzies, AM, Nieweg, OE, O'Brien, BH, Pennington, TE, Potter, AJ, Prakash, S, Rawson, RV, Read, RL, Rtshiladze, MA, Shannon, KF, O'Toole, Sandra, Smithers, BM, Spillane, AJ, Stretch, JR, Thompson, JF, Tucker, P, Varey, AHR, Vilain, Ricardo E., Wood, BA, Long, GV, Saw, Robyn P. M., Amanuel, Benhur, Angel, Christopher M., Button-Sloan, Alison E., Carlino, Matteo S.
المساهمون: The University of Newcastle. College of Health, Medicine & Wellbeing, School of Medicine and Public Health
مصطلحات موضوعية: stage IV melanoma, stage III melanoma, metastatic melanoma, pathology, diagnosis, treatment, SDG 3, Sustainable Development Goals
العلاقة: Pathology Vol. 54, Issue 1, p. 6-19; http://hdl.handle.net/1959.13/1465756Test; uon:47367
-
5دورية أكاديمية
المؤلفون: Robert, Caroline, Hwu, Wen-Jen, Hamid, Omid, Ribas, Antoni, Weber, Jeffrey S, Daud, Adil I, Hodi, F Stephen, Wolchok, Jedd D, Mitchell, Tara C, Hersey, Peter, Dronca, Roxana, Joseph, Richard W, Boutros, Celine, Min, Le, Long, Georgina V, Schachter, Jacob, Puzanov, Igor, Dummer, Reinhard, Lin, Jianxin, Ibrahim, Nageatte, Diede, Scott J, Carlino, Matteo S, Joshua, Anthony M
-
6دورية أكاديمية
المؤلفون: Ch'ng, Sydney, Uyulmaz, Semra, Carlino, Matteo S, Pennington, Thomas E, Shannon, Kerwin F, Rtshiladze, Michael, Stretch, Jonathan R, Nieweg, Omgo E, Varey, Alexander H R, Hsiao, Edward, Kapoor, Rony, Pires da Silva, Ines, Lo, Serigne N, Spillane, Andrew J, Scolyer, Richard A, Long, Georgina V, Hong, Angela M, Saw, Robyn P M, Thompson, John F, Menzies, Alexander M
المصدر: Ch'ng, Sydney; Uyulmaz, Semra; Carlino, Matteo S; Pennington, Thomas E; Shannon, Kerwin F; Rtshiladze, Michael; Stretch, Jonathan R; Nieweg, Omgo E; Varey, Alexander H R; Hsiao, Edward; Kapoor, Rony; Pires da Silva, Ines; Lo, Serigne N; Spillane, Andrew J; Scolyer, Richard A; Long, Georgina V; Hong, Angela M; Saw, Robyn P M; Thompson, John F; Menzies, Alexander M (2021). Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies. European Journal of Cancer, 153:8-15.
مصطلحات موضوعية: Clinic for Reconstructive Surgery, 610 Medicine & health
العلاقة: https://www.zora.uzh.ch/213921Test; info:pmid/34126335; urn:issn:0959-8049
الإتاحة: https://doi.org/10.1016/j.ejca.2021.04.037Test
https://www.zora.uzh.ch/id/eprint/213921Test/
https://www.zora.uzh.ch/213921Test -
7دورية أكاديمية
المؤلفون: Robert, Caroline, Hwu, Wen-Jen, Hamid, Omid, Ribas, Antoni, Weber, Jeffrey S., Daud, Adil I., Hodi, F. Stephen, Wolchok, Jedd D., Mitchell, Tara C., Hersey, Peter, Dronca, Roxana, Joseph, Richard W., Boutros, Celine, Min, Le, Long, Georgina V., Schachter, Jacob, Puzanov, Igor, Dummer, Reinhard, Lin, Jianxin, Ibrahim, Nageatte, Diede, Scott J., Carlino, Matteo S., Joshua, Anthony M.
المساهمون: Intégrité du génome, ARN et cancer, Institut Curie Paris -Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)
المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.archives-ouvertes.fr/hal-03492707Test ; European Journal of Cancer, Elsevier, 2021, 144, pp.182 - 191. ⟨10.1016/j.ejca.2020.11.010⟩.
مصطلحات موضوعية: [SDV]Life Sciences [q-bio]
العلاقة: hal-03492707; https://hal.archives-ouvertes.fr/hal-03492707Test; PII: S0959-8049(20)31333-2
الإتاحة: https://doi.org/10.1016/j.ejca.2020.11.010Test
https://hal.archives-ouvertes.fr/hal-03492707Test -
8دورية أكاديمية
المؤلفون: Long, Georgina V, Dummer, Reinhard, Hamid, Omid, Gajewski, Thomas F, Caglevic, Christian, Dalle, Stephane, Arance, Ana, Carlino, Matteo S, Grob, Jean-Jacques, Kim, Tae Min, Demidov, Lev, Robert, Caroline, Larkin, James, Anderson, James R, Maleski, Janet, Jones, Mark, Diede, Scott J, Mitchell, Tara C
-
9دورية أكاديمية
المؤلفون: Long, Georgina V, Dummer, Reinhard, Hamid, Omid, Gajewski, Thomas F, Caglevic, Christian, Dalle, Stephane, Arance, Ana, Carlino, Matteo S, Grob, Jean-Jacques, Kim, Tae Min, Demidov, Lev, Robert, Caroline, Larkin, James, Anderson, James R, Maleski, Janet, Jones, Mark, Diede, Scott J, Mitchell, Tara C
المصدر: Long, Georgina V; Dummer, Reinhard; Hamid, Omid; Gajewski, Thomas F; Caglevic, Christian; Dalle, Stephane; Arance, Ana; Carlino, Matteo S; Grob, Jean-Jacques; Kim, Tae Min; Demidov, Lev; Robert, Caroline; Larkin, James; Anderson, James R; Maleski, Janet; Jones, Mark; Diede, Scott J; Mitchell, Tara C (2019). Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study. Lancet Oncology, 20(8):1083-1097.
مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health
وصف الملف: application/pdf
العلاقة: https://www.zora.uzh.ch/id/eprint/172887/1/805_Long_GV._et_al._Epacadostat_plus_pembrolizumab_versus_placebo_plus_pembrolizumab_in_patients_with_unresectable_or_metastatic_melanoma_etc._Lancet_Oncol_2019.pdfTest; info:pmid/31221619; urn:issn:1470-2045
الإتاحة: https://doi.org/10.5167/uzh-17288710.1016/S1470-2045Test(19)30274-8
https://www.zora.uzh.ch/id/eprint/172887Test/
https://www.zora.uzh.ch/id/eprint/172887/1/805_Long_GV._et_al._Epacadostat_plus_pembrolizumab_versus_placebo_plus_pembrolizumab_in_patients_with_unresectable_or_metastatic_melanoma_etc._Lancet_Oncol_2019.pdfTest -
10دورية أكاديمية
المؤلفون: Valpione, Sara, Carlino, Matteo S, Mangana, Johanna, et al